Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin–Piperaquine in Southern Province, Zambia-Reference-Cited by-同舟云学术

Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin–Piperaquine in Southern Province, Zambia

Published:2020-08-06 Issue:2_Suppl Volume:103 Page:19-27
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Finn Timothy P.¹,Yukich Joshua O.¹,Bennett Adam²,Porter Travis R.¹,Lungu Christopher³,Hamainza Busiku⁴,Chizema Kawesha Elizabeth⁴,Conner Ruben O.⁵,Silumbe Kafula³,Steketee Richard W.⁵,Miller John M.³,Keating Joseph¹,Eisele Thomas P.¹

Affiliation:

1. Department of Tropical Medicine, Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana;

2. Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, California;

3. PATH Malaria Control and Elimination Partnership in Africa (MACEPA), Lusaka, Zambia;

4. National Malaria Elimination Centre, Zambia Ministry of Health, Chainama Hospital, Lusaka, Zambia;

5. PATH MACEPA, Seattle, Washington

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference52 articles.

1. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial;Eisele;J Infect Dis,2016

2. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study;Brady;Lancet Glob Health,2017

3. Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia’s Southern Province: a simulation study;Stuckey;Malar J,2016